SCHEMBL12472369

SCHEMBL12472369

C[C@H](NC(=O)OC(C)(C)C)c1nc2ccc(F)c(Br)c2n1-c1ccccn1.C[C@H](Nc1ncnc2c1ncn2C1CCCCO1)c1nc2ccc(F)c(Br)c2n1-c1ccccn1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CYP2C19 P33261 1/20 0.36
▸ FLT3 P36888 3/20 0.34
▸ PIK3CD O00329 1/20 0.33
▸ PIK3R1 P27986 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ HPGD P15428 1/20 0.32
▸ YTHDC1 Q96MU7 1/20 0.32
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11964435 0.91 NPC1 (0.47) NPC1RAB9ASMN1; SMN2CYP2C19FLT3
SCHEMBL11902184 0.83 NPC1 (0.45) NPC1RAB9ASMN1; SMN2CYP2C19FLT3
SCHEMBL11901800 0.83 NPC1 (0.51) NPC1RAB9ASMN1; SMN2CYP2C19FLT3
SCHEMBL11901810 0.80 PIK3CD (0.35) NPC1RAB9APIK3CDPIK3R1PIK3CA
SCHEMBL11901167 0.78 NPC1 (0.47) NPC1RAB9ASMN1; SMN2CYP2C19FLT3
SCHEMBL11901170 0.78 NPC1 (0.47) NPC1RAB9ASMN1; SMN2CYP2C19FLT3
SCHEMBL11901249 0.77 NPC1 (0.45) NPC1RAB9ASMN1; SMN2CYP2C19FLT3
SCHEMBL11901248 0.77 NPC1 (0.45) NPC1RAB9ASMN1; SMN2CYP2C19FLT3
SCHEMBL11964439 0.77 NPC1 (0.46) NPC1RAB9ASMN1; SMN2CYP2C19FLT3
SCHEMBL11964441 0.75 NPC1 (0.51) NPC1RAB9ASMN1; SMN2CYP2C19FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2673269-A1 HETEROCYCLIC COMPOUNDS AS PI3 KINASE INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2013-12-18 — — EP disclosed
WO-2012107465-A1 HETEROCYCLIC COMPOUNDS AS PI3 KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-08-16 — — WO disclosed
Send feedback